pseudomycin analogs (Lilly)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namepseudomycin analogs (Lilly)
Drug Alias Namepseudomycin Apseudomycin CPseudomycin A'Pseudomycin C'pseudomycin B +[10] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Montana
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And CompanyUniversity Of Montana
Active IndicationsN/A
Inactive IndicationsMycoses

Other Information

ATC CodeN/A
Related LinksN/A